The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels

10.1016/S0140-6736(77)91701-9

10.1016/S0140-6736(86)90597-0

10.1056/NEJM199006143222403

10.1016/S0002-9149(99)80474-3

10.1016/S0002-9149(99)80476-7

10.1016/S0002-9149(99)80475-5

10.1016/S0140-6736(94)90506-1

1994, Lancet, 344, 1383

10.1056/NEJM199511163332001

Byington RP, 1995, Circulation, 92, 2419, 10.1161/01.CIR.92.9.2419

10.1016/S0002-9149(99)80465-2

10.1001/jama.269.23.3002

10.1016/0002-9149(91)90500-K

Buring JE, 1992, Circulation, 85, 22, 10.1161/01.CIR.85.1.22

10.1016/0735-1097(92)90520-W

10.1016/S0002-9149(99)80761-9

10.1016/0002-9149(91)90276-Q

10.1001/jama.269.23.3015

Friedewald WT, 1972, Clin Chem, 18, 499, 10.1093/clinchem/18.6.499

Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: John Wiley, 1980.

Cox DR, 1972, J R Stat Soc [B], 34, 187

Dayton S, 1969, Circulation, 40, II, 10.1161/01.CIR.40.1S2.II-1

10.1001/jama.231.4.360

10.1016/S0002-9149(99)80580-3

Salonen R, 1995, Circulation, 92, 1758, 10.1161/01.CIR.92.7.1758

Furberg CD, 1994, Circulation, 90, 1679, 10.1161/01.CIR.90.4.1679

10.1001/jama.275.1.55

10.1016/0026-0495(93)90272-P

Ries LA, Miller BA, Hankey BF, Kosary CL, Haras A, Edwards BK, eds. SEER cancer statistics review, 1973-1991: tables and graphs. Bethesda, Md.: National Cancer Institute, 1994. (NIH publication no. 94-2789.)

10.1016/S0002-9149(99)80133-7

10.1016/S0002-9149(99)80478-0